INDOUSNSEIndo Us Biotech LimitedMediumNeutral
Announced Tue, 16 Jun · 17:47 IST

Statutory and Internal Auditor changes at Indo Us Bio Tech

Auditor Resigned MidtermManagement Changes View source PDF

INDOUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+5.9%1-day move
₹89.00
prior close
₹87.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+4.1+2.7+3.5+4.1+5.9+1.7+4.2+0.8+0.0+0.2+0.0-1.5
Up moveDown movePending
AI summary

Board approved changes to both auditors on June 16, 2026. Statutory auditor M/s. Gautam N Associates resigned effective June 15, citing administrative and operational restructuring of audit assignments; M/s. Bhagat & Associates (Ahmedabad-based) appointed in their place from June 16, subject to shareholder approval. Internal auditor M/s. Raj Shah & Co. also resigned effective June 15, with M/s. J. M. Raval & Co. appointed for five years (FY2026-27 to FY2030-31). The outgoing statutory auditor noted the switch was to enable closer local coordination from Ahmedabad.

Likely market impact

Mid-term auditor changes can raise governance flags for investors, though reason cited is operational restructuring. New statutory auditor appointment needs shareholder approval at the next AGM.